Zenodo
Lipoprotein(a): A genetically determined risk marker in type 2 diabetes and obesity
By Najmutdinova D.K. and Sadikova A.S..
Abstract
Lipoprotein(a) [Lp(a)] is a genetically determined, independent, and causal risk factor for atherosclerotic cardiovascular disease and calcific aortic valve stenosis, with elevated levels found in approximately 20% of the global population. Unlike most lipid parameters, Lp(a) is largely unaffected by lifestyle modification or statin therapy, making it one of the main contributors to residual atherogenic risk even when target LDL-cholesterol levels are achieved. Lp(a) acquires particular clinical relevance in patients with type 2 diabetes mellitus (T2DM) and obesity — a population with inherently elevated cardiometabolic risk, in whom its relationship with Lp(a) is complex.
Keywords
- Lipoproteins and Cardiovascular Health
- Type 2 diabetes
- Obesity
- Diabetes mellitus
- Disease
- Risk factor
- Type 2 Diabetes Mellitus
- Population
- Residual risk
- Open access
Source
Published in Zenodo (CERN European Organization for Nuclear Research). The abstract is shown as published and remains the work of its authors; read the full article at the source.
Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.
